%PDF-1.6
%
3 0 obj
<>
endobj
23 0 obj
[/CalGray<>]
endobj
24 0 obj
[/CalRGB<>]
endobj
25 0 obj
<>stream
application/pdf
Commission de la transparence
Zyprexa VeloTab, Olanzapine, Avis de transparence
Avis de transparence Zyprexa VeloTab, Olanzapine, inscription, juin 2001
Zyprexa VeloTab
Olanzapine
Comprimés orodispersibles
5mg
10mg
15mg
20mg
schizophrénie
avis
transparence
inscription
Lilly
ASMR
SMR
population cible
2001
2001-09-03T15:18:33Z
Microsoft Word
2013-07-25T14:39:32+02:00
2013-07-25T14:39:32+02:00
Acrobat PDFWriter 5.0 pour Windows
Zyprexa VeloTab, Olanzapine, Comprimés orodispersibles; 5mg; 10mg; 15mg; 20mg, schizophrénie, avis, transparence, inscription, Lilly, ASMR, SMR, population cible, 2001
uuid:03e31c3b-a37e-4829-b705-25a58dfd9e97
uuid:14dc7813-7fac-4b6f-b585-a6c1986d983c
endstream
endobj
5 0 obj
<>
endobj
4 0 obj
<>/ProcSet 2 0 R>>/Type/Page>>
endobj
12 0 obj
<>/ProcSet 2 0 R>>/Type/Page>>
endobj
17 0 obj
<>/ProcSet 2 0 R>>/Type/Page>>
endobj
20 0 obj
<>/ProcSet 2 0 R>>/Type/Page>>
endobj
21 0 obj
<>stream
HVn6ü5[^/')rYnya$Bn!i{Y$K̙3s$ a`q3b@>~is9 9Z Ft]A^Wy߶*K_8`d>~f{xc< (\7ڠ}CV~iMD[b Кg/ NB ŀ$t^*xBPp% 'ƪ;Zε,%&,['l"O^cN;